| 05/19 | QIAGEN's Eco-Friendlier Products Earn Prestigious ACT Label | BU |
| 05/16 | QIAGEN NV : Berenberg keeps its Buy rating | MD |
| 05/16 | QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D.. | BU |
| 05/16 | QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D.. | CI |
| 05/11 | SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close | MT |
| 05/11 | SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance | MT |
| 05/11 | Qiagen to Acquire 96% Stake In BLIRT for Undisclosed Sum | MT |
| 05/11 | QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | BU |
| 05/11 | QIAGEN Proposes Expansion of Supervisory Board | BU |
| 05/11 | Qiagen N.V. agreed to acquire 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian.. | CI |
| 05/10 | TRANSCRIPT : QIAGEN N.V. Presents at Bank of America 2022 Healthcare Conference, May-10-20.. | CI |
| 05/05 | QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated.. | BU |
| 04/29 | QIAGEN N.V. : Release of a capital market information | EQ |
| 04/29 | QIAGEN NV : Buy rating from JP Morgan | MD |
| 04/28 | TRANSCRIPT : Qiagen N.V., Q1 2022 Earnings Call, Apr 28, 2022 | CI |
| 04/28 | Qiagen N.V. Reports Earnings Results for the First Quarter Ended March 31, 2022 | CI |
| 04/28 | Qiagen sees no immediate impact from global supply bottlenecks | RE |
| 04/27 | QIAGEN NV : UBS gives a Neutral rating | MD |
| 04/27 | QIAGEN NV : Gets a Buy rating from Deutsche Bank | MD |
| 04/26 | Diagnostics Group Qiagen Raises FY22 Guidance After Exceeding Sales Expectations in Q1 | MT |
| 04/26 | Qiagen Reports Higher Q1 Results, Raises 2022 Outlook | MT |
| 04/26 | QIAGEN : Q1 Earnings Snapshot | AQ |
| 04/26 | QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID.. | BU |
| 04/26 | Qiagen Trading Halted Pending News Release; Shares Down 2.2% at Last Look | MT |
| 04/26 | Qiagen N.V. Revises Net Sales Guidance for the Full Year 2022 | CI |
| 04/26 | QIAGEN N.V. : QIAGEN increases full-year 2022 outlook | EQ |
| 04/25 | QIAGEN N : gives drug research direct access to world-leading data with launch of Biomedic.. | PU |
| 04/21 | QIAGEN N : Certificate Product Life Cycle Assessment | PU |
| 04/20 | QIAGEN N.V. to release results for Q1 2022 and hold Webcast | BU |
| 04/20 | QIAGEN NV : DZ Bank maintains a Buy rating | MD |
| 04/14 | QIAGEN NV : Deutsche Bank reaffirms its Buy rating | MD |
| 04/07 | QIAGEN N : EZ2 Connect wins prestigious Red Dot design award | PU |
| 04/05 | QIAGEN N.V. : Notification and public disclosure of transactions by persons | EQ |
| 04/05 | QIAGEN NV : DZ Bank reiterates its Buy rating | MD |
| 03/31 | QIAGEN N : Global Environmental Health Safety Policy | PU |
| 03/25 | QIAGEN N.V. : Notification and public disclosure of transactions by persons | EQ |
| 03/24 | Qiagen Reaches Milestone With 100 Million Blood Tests Used to Detect Tuberculosis | MT |
| 03/24 | QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB | BU |
| 03/18 | QIAGEN N.V. : Notification and public disclosure of transactions by persons | EQ |
| 03/15 | TRANSCRIPT : QIAGEN N.V. Presents at Barclays Global Healthcare Conference 2022, Mar-15-20.. | CI |
| 03/14 | QIAGEN Announces 20-F Annual Report Filing for 2021 Results | BU |
| 03/14 | QIAGEN N : Annual Report by Foreign Issuer (Form 20-F) | PU |
| 03/14 | Tranche Update on QIAGEN N.V.'s Equity Buyback Plan announced on July 20, 2021. | CI |
| 03/08 | TRANSCRIPT : QIAGEN N.V. Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022.. | CI |
| 03/03 | QIAGEN N.V. : Notification and public disclosure of transactions by persons | EQ |
| 03/02 | QIAGEN N : and NHS England deepen bioinformatics relationship with agreement for HGMD Prof.. | PU |
| 02/28 | Singular Genomics Partners with Qiagen to Enable QIAseq Kits for the G4 Sequencing Plat.. | CI |
| 02/23 | QIAGEN N.V. : Notification and public disclosure of transactions by persons | EQ |
| 02/23 | TRANSCRIPT : QIAGEN N.V. Presents at Citi’s 2022 Virtual Healthcare Conference, Feb-2.. | CI |
| 02/22 | Element Biosciences Partners with Qiagen to Validate a Selection of Qiaseq Targeted Lib.. | CI |
| 02/17 | QIAGEN NV : Receives a Buy rating from DZ Bank | MD |
| 02/10 | UBS Adjusts Qiagen N.V Price Target to $55 From $57, Maintains Neutral Rating | MT |
| 02/09 | QIAGEN NV : Goldman Sachs reiterates its Neutral rating | MD |
| 02/09 | TRANSCRIPT : QIAGEN N.V., Q4 2021 Earnings Call, Feb 09, 2022 | CI |
| 02/09 | QIAGEN : Q4 Earnings Snapshot | AQ |
| 02/09 | QIAGEN NV : Deutsche Bank reiterates its Buy rating | MD |
| 02/09 | QIAGEN NV : Jefferies sticks Neutral | MD |
| 02/08 | Qiagen forecasts profit above estimates as non-COVID businesses rebound | RE |
| 02/08 | Qiagen N.V Q4 Results Top Street Expectations, Sets Upbeat EPS Guidance | MT |
| 02/08 | QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year .. | BU |
| 02/08 | QIAGEN N.V. Provides Sales Guidance for the First Quarter and Full Year of 2022 | CI |
| 02/08 | EARNINGS REACTION HISTORY : Qiagen N V, 50.0% Follow-Through Indicator, 2.0% Sensitive | MT |
| 02/08 | QIAGEN N.V. Reports Earnings Results for the Full Year Ended December 31, 2021 | CI |
| 02/08 | QIAGEN N.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 | CI |
| 02/07 | Qiagen Gets Chinese Regulatory Approval for Tuberculosis Test | MT |
| 02/07 | QIAGEN's New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO R.. | BU |
| 02/07 | Qiagen N.V. Announces New Generation of Quantiferon TB Test Gains Chinese Approval and .. | CI |
| 01/27 | QIAGEN's Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign a.. | BU |
| 01/25 | QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QI.. | BU |
| 01/25 | QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QI.. | CI |
| 01/21 | QIAGEN N : Earnings Document | PU |
| 01/19 | Qiagen N.V Launched Higher on M&A Chatter | MT |
| 01/19 | QIAGEN N : supports young biotechnology and pharma companies by announcing winners of firs.. | PU |
| 01/19 | QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021 | BU |
| 01/18 | QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products | BU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
